Cargando…

Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest

INTRODUCTION: Apparent diffusion coefficient (ADC) values are increasingly reported in breast MRI. As there is no standardized method for ADC measurements, we evaluated the effect of the size of region of interest (ROI) to diagnostic utility and correlation to prognostic markers of breast cancer. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Arponent, Otso, Sudah, Mazen, Masarwah, Amro, Taina, Mikko, Rautiainen, Suvi, Könönen, Mervi, Sironen, Reijo, Kosma, Veli-Matti, Sutela, Anna, Hakumäki, Juhana, Vanninen, Ritva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601774/
https://www.ncbi.nlm.nih.gov/pubmed/26458106
http://dx.doi.org/10.1371/journal.pone.0138702
_version_ 1782394593524842496
author Arponent, Otso
Sudah, Mazen
Masarwah, Amro
Taina, Mikko
Rautiainen, Suvi
Könönen, Mervi
Sironen, Reijo
Kosma, Veli-Matti
Sutela, Anna
Hakumäki, Juhana
Vanninen, Ritva
author_facet Arponent, Otso
Sudah, Mazen
Masarwah, Amro
Taina, Mikko
Rautiainen, Suvi
Könönen, Mervi
Sironen, Reijo
Kosma, Veli-Matti
Sutela, Anna
Hakumäki, Juhana
Vanninen, Ritva
author_sort Arponent, Otso
collection PubMed
description INTRODUCTION: Apparent diffusion coefficient (ADC) values are increasingly reported in breast MRI. As there is no standardized method for ADC measurements, we evaluated the effect of the size of region of interest (ROI) to diagnostic utility and correlation to prognostic markers of breast cancer. METHODS: This prospective study was approved by the Institutional Ethics Board; the need for written informed consent for the retrospective analyses of the breast MRIs was waived by the Chair of the Hospital District. We compared diagnostic accuracy of ADC measurements from whole-lesion ROIs (WL-ROIs) to small subregions (S-ROIs) showing the most restricted diffusion and evaluated correlations with prognostic factors in 112 consecutive patients (mean age 56.2±11.6 years, 137 lesions) who underwent 3.0-T breast MRI. RESULTS: Intra- and interobserver reproducibility were substantial (κ = 0.616–0.784; Intra-Class Correlation 0.589–0.831). In receiver operating characteristics analysis, differentiation between malignant and benign lesions was excellent (area under curve 0.957–0.962, cut-off ADC values for WL-ROIs: 0.87×10(−3) mm(2)s(-1); S-ROIs: 0.69×10(−3) mm(2)s(-1), P<0.001). WL-ROIs/S-ROIs achieved sensitivities of 95.7%/91.3%, specificities of 89.5%/94.7%, and overall accuracies of 89.8%/94.2%. In S-ROIs, lower ADC values correlated with presence of axillary metastases (P = 0.03), high histological grade (P = 0.006), and worsened Nottingham Prognostic Index Score (P<0.05). In both ROIs, ADC values correlated with progesterone receptors and advanced stage (P<0.01), but not with HER2, estrogen receptors, or Ki-67. CONCLUSIONS: ADC values assist in breast tumor characterization. Small ROIs were more accurate than whole-lesion ROIs and more frequently associated with prognostic factors. Cut-off values differed significantly depending on measurement procedure, which should be recognized when comparing results from the literature. Instead of using a whole lesion covering ROI, a small ROI could be advocated in diffusion-weighted imaging.
format Online
Article
Text
id pubmed-4601774
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46017742015-10-20 Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest Arponent, Otso Sudah, Mazen Masarwah, Amro Taina, Mikko Rautiainen, Suvi Könönen, Mervi Sironen, Reijo Kosma, Veli-Matti Sutela, Anna Hakumäki, Juhana Vanninen, Ritva PLoS One Research Article INTRODUCTION: Apparent diffusion coefficient (ADC) values are increasingly reported in breast MRI. As there is no standardized method for ADC measurements, we evaluated the effect of the size of region of interest (ROI) to diagnostic utility and correlation to prognostic markers of breast cancer. METHODS: This prospective study was approved by the Institutional Ethics Board; the need for written informed consent for the retrospective analyses of the breast MRIs was waived by the Chair of the Hospital District. We compared diagnostic accuracy of ADC measurements from whole-lesion ROIs (WL-ROIs) to small subregions (S-ROIs) showing the most restricted diffusion and evaluated correlations with prognostic factors in 112 consecutive patients (mean age 56.2±11.6 years, 137 lesions) who underwent 3.0-T breast MRI. RESULTS: Intra- and interobserver reproducibility were substantial (κ = 0.616–0.784; Intra-Class Correlation 0.589–0.831). In receiver operating characteristics analysis, differentiation between malignant and benign lesions was excellent (area under curve 0.957–0.962, cut-off ADC values for WL-ROIs: 0.87×10(−3) mm(2)s(-1); S-ROIs: 0.69×10(−3) mm(2)s(-1), P<0.001). WL-ROIs/S-ROIs achieved sensitivities of 95.7%/91.3%, specificities of 89.5%/94.7%, and overall accuracies of 89.8%/94.2%. In S-ROIs, lower ADC values correlated with presence of axillary metastases (P = 0.03), high histological grade (P = 0.006), and worsened Nottingham Prognostic Index Score (P<0.05). In both ROIs, ADC values correlated with progesterone receptors and advanced stage (P<0.01), but not with HER2, estrogen receptors, or Ki-67. CONCLUSIONS: ADC values assist in breast tumor characterization. Small ROIs were more accurate than whole-lesion ROIs and more frequently associated with prognostic factors. Cut-off values differed significantly depending on measurement procedure, which should be recognized when comparing results from the literature. Instead of using a whole lesion covering ROI, a small ROI could be advocated in diffusion-weighted imaging. Public Library of Science 2015-10-12 /pmc/articles/PMC4601774/ /pubmed/26458106 http://dx.doi.org/10.1371/journal.pone.0138702 Text en © 2015 Arponent et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Arponent, Otso
Sudah, Mazen
Masarwah, Amro
Taina, Mikko
Rautiainen, Suvi
Könönen, Mervi
Sironen, Reijo
Kosma, Veli-Matti
Sutela, Anna
Hakumäki, Juhana
Vanninen, Ritva
Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title_full Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title_fullStr Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title_full_unstemmed Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title_short Diffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of Interest
title_sort diffusion-weighted imaging in 3.0 tesla breast mri: diagnostic performance and tumor characterization using small subregions vs. whole tumor regions of interest
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601774/
https://www.ncbi.nlm.nih.gov/pubmed/26458106
http://dx.doi.org/10.1371/journal.pone.0138702
work_keys_str_mv AT arponentotso diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT sudahmazen diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT masarwahamro diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT tainamikko diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT rautiainensuvi diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT kononenmervi diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT sironenreijo diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT kosmavelimatti diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT sutelaanna diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT hakumakijuhana diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest
AT vanninenritva diffusionweightedimagingin30teslabreastmridiagnosticperformanceandtumorcharacterizationusingsmallsubregionsvswholetumorregionsofinterest